Cargando…
Transitioning From Thrombopoietin Agonists to the Novel SYK Inhibitor Fostamatinib: A Multicenter, Real-World Case Series
Fostamatinib is an oral spleen tyrosine kinase (SYK) inhibitor used for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. Clinical and operational barriers may exist that warrant bridging or switching from thromb...
Autores principales: | Hughes, David M., Toste, Charina, Nelson, Christopher, Escalon, Juliet, Blevins, Frances, Shah, Bhavesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299792/ https://www.ncbi.nlm.nih.gov/pubmed/34430061 http://dx.doi.org/10.6004/jadpro.2021.12.5.6 |
Ejemplares similares
-
Ganciclovir Therapeutic Drug Monitoring: A Case Series
por: Märtson, Anne-Grete, et al.
Publicado: (2019) -
Can platelet count be controlled with ticagrelor in patients with essential thrombocythaemia? A case series
por: Yılmaz, Samet, et al.
Publicado: (2023) -
Intracoronary IgG4-related disease as an unusual cause of sudden cardiac arrest: a case series
por: Paratz, Elizabeth D, et al.
Publicado: (2022) -
Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry’s
disease
por: Nandagudi, A, et al.
Publicado: (2013) -
Successful treatment of suspected early form of chronic Chagas cardiomyopathy: a case report
por: Lu, Nelson, et al.
Publicado: (2022)